Zynerba Pharmaceuticals Reports First Quarter 2019 Financial Results and Operational Highlights
The Company’s cash and cash equivalent position as of March 31, 2019 was $68.3 million.
Read More
MediPharm Labs Sets Date to Release First Quarter 2019 Financial Results
MediPharm Labs Corp. will release its first quarter financial results for the three months ended March 31, 2019 on Friday, May 10, 2019.
Read More
Cara Therapeutics Reports First Quarter 2019 Financial Results
The Company reported a net loss of $22.0 million, or $0.56 per basic and diluted share, for the first quarter of 2019.
Read More
GW Pharmaceuticals plc Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2019
Epidiolex U.S. reported a Q1 net sales of $33.5m.
Read More
Medtainer Inc. Financials update
The reason that the report has not been filed arises from the Company’s acquisition of the patents and trademark relating to its Medtainer products and a related website in June 2018 in exchange for shares of its common stock.
Read More
ScottsMiracle-Gro Reports Strong Second Quarter Financial Results Driven by Strong Start to U.S. Lawn & Garden Season
For the quarter ended March 30, 2019, GAAP earnings from continuing operations were $7.10 per share compared with $2.66 per share in the prior year.
Read More
WeedMD Reports Fiscal Year 2018 Financial Results
WeedMD reports revenues of $8.2M in its second year of operations representing a year-over-year increase of 465%.
Read More
Golden Leaf Reports Fiscal Year 2018 Results
The company announced financial results for the fiscal year ended December 31, 2018, and a general business update.
Read More
Cara Therapeutics to Announce First Quarter 2019 Financial Results on May 7, 2019
The company will host a conference call and live audio webcast on Tuesday, May 7, 2019, at 4:30 p.m. ET to report first quarter 2019 financial results and provide a corporate update.
Read More
Aleafia Health Reports 2018 Fiscal Year-end Results, Provides Corporate Update
Aleafia Health has filed today its audited consolidated financial statements and related management’s discussion and analysis, both of which are available on Aleafia Health’s profile at www.SEDAR.com.
Read MoreGET LISTED
